DE69625189D1 - Tablette mit gesteuerter freisetzung - Google Patents

Tablette mit gesteuerter freisetzung

Info

Publication number
DE69625189D1
DE69625189D1 DE69625189T DE69625189T DE69625189D1 DE 69625189 D1 DE69625189 D1 DE 69625189D1 DE 69625189 T DE69625189 T DE 69625189T DE 69625189 T DE69625189 T DE 69625189T DE 69625189 D1 DE69625189 D1 DE 69625189D1
Authority
DE
Germany
Prior art keywords
controlled release
release tablet
tablet
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625189T
Other languages
English (en)
Inventor
Cherng-Ju Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Application granted granted Critical
Publication of DE69625189D1 publication Critical patent/DE69625189D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
DE69625189T 1995-02-28 1996-02-28 Tablette mit gesteuerter freisetzung Expired - Lifetime DE69625189D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39579295A 1995-02-28 1995-02-28
PCT/US1996/002290 WO1996026718A2 (en) 1995-02-28 1996-02-28 Controlled release tablet

Publications (1)

Publication Number Publication Date
DE69625189D1 true DE69625189D1 (de) 2003-01-16

Family

ID=23564527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625189T Expired - Lifetime DE69625189D1 (de) 1995-02-28 1996-02-28 Tablette mit gesteuerter freisetzung

Country Status (11)

Country Link
EP (1) EP0821582B1 (de)
JP (1) JPH11509169A (de)
AR (1) AR003928A1 (de)
AT (1) ATE228829T1 (de)
AU (1) AU722741B2 (de)
CA (1) CA2213455A1 (de)
DE (1) DE69625189D1 (de)
MY (1) MY113429A (de)
PA (1) PA8388101A1 (de)
TW (1) TW431891B (de)
WO (1) WO1996026718A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
WO1998029095A2 (en) * 1997-01-03 1998-07-09 Elan Corporation, Plc Sustained release cisapride mini-tablet formulation
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
IL150568A0 (en) 2000-02-04 2003-02-12 Depomed Inc A controlled release oral drug dosage form
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US6723340B2 (en) * 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
NZ541008A (en) 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
MXPA06014587A (es) 2004-06-17 2007-04-27 Forest Laboratories Formulaciones de liberacion modificada de formulaciones de dosificacion oral de memantina.
BRPI0617382A2 (pt) 2005-10-14 2017-07-11 H Lundbeck As Métodos para tratar um distúrbio do sistema nervoso central em um paciente, para tratar um paciente sofrendo de condições e uma disfunção sexual, e para reduzir um retardo na eficácia terapêutica em seguida ao início do tratamento
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
WO2010026467A2 (en) 2008-09-04 2010-03-11 Torrent Pharmaceuticals Ltd. Controlled release dosage form of high solubility active ingredient
EA201101524A1 (ru) 2009-04-20 2012-07-30 Элселикс Терапьютикс, Инк. Способ и композиция для лечения состояния, связанного с хемосенсорным рецептором
US8828953B2 (en) 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
AU2011317140A1 (en) 2010-10-19 2013-05-30 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
SG10201607085WA (en) 2011-01-07 2016-10-28 Elcelyx Therapeutics Inc Chemosensory Receptor Ligand-Based Therapies
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
US9617230B2 (en) 2014-12-22 2017-04-11 Farmington Pharma Development Creatine prodrugs, compositions and methods of use thereof
CA3082184A1 (en) 2017-12-01 2019-06-06 Ultragenyx Pharmaceutical Inc. Creatine prodrugs, compositions and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed

Also Published As

Publication number Publication date
CA2213455A1 (en) 1996-09-06
EP0821582B1 (de) 2002-12-04
MY113429A (en) 2002-02-28
AU5171196A (en) 1996-09-18
EP0821582A2 (de) 1998-02-04
JPH11509169A (ja) 1999-08-17
WO1996026718A2 (en) 1996-09-06
AR003928A1 (es) 1998-09-30
AU722741B2 (en) 2000-08-10
TW431891B (en) 2001-05-01
WO1996026718A3 (en) 1996-10-10
PA8388101A1 (es) 1997-09-30
ATE228829T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DE69617245D1 (de) Produkte mit gesteuerter freisetzung
DE69128569D1 (de) Tablette mit verzögerter Wirkstoffabgabe
DK0840634T3 (da) Transcornealt lægemiddelfrigivelsessystem
FI20030560A (fi) Hallitusti vapauttava valmiste
ZA96448B (en) Tablet
DE69620003D1 (de) Freisetzungssysteme
DE69401971D1 (de) Magnetothermische Auslöseeinheit
NO962510D0 (no) Dobbel-væskemedikamentfordeler
DE69625954D1 (de) Standbildkamera
IL123614A0 (en) Chewable tablet
FR2737885B3 (fr) Distributeur de comprimes
AU128017S (en) Pharmaceutical tablet
DE69632787D1 (de) Pharmazeutische pellets
BR9610193A (pt) 4-Tiocarbamoil-1-(2-Pirazolil)-pirazóis
AU129056S (en) Pharmaceutical tablet
ATE240096T1 (de) Schnellfreisetzende komprimierte flurbiprofen enthaltende tablette
KR970008018U (ko) 장제용 위패
DE19680143T1 (de) Fotoapparat
SE9500250D0 (sv) Portionstabletter
UA1292S (uk) Таблетка фармацевтична
FI950008A (fi) Farmaseuttinen koostumus kontrolloitua vapautumista varten
CA77348S (en) Tablet
DE69617790D1 (de) Synchronisierter Zeitschalter

Legal Events

Date Code Title Description
8332 No legal effect for de